Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea · Delayed Price · Currency is KRW 1,534.00
+128.00 (9.10%)
Jul 1, 2026, 3:30 PM KST
Cellid, Market Cap
Cellid, has a market cap or net worth of 41.48 billion as of June 30, 2026. Its market cap has decreased by -72.92% in one year.
Market Cap
41.48B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1,534.00
Market Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 41.48B, a decrease of -91.40%. That is a compound annual growth rate of -28.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 41.48B | -50.84% |
| Dec 30, 2025 | 84.38B | -20.98% |
| Dec 30, 2024 | 106.78B | 75.61% |
| Dec 28, 2023 | 60.81B | -46.82% |
| Dec 29, 2022 | 114.34B | -76.07% |
| Dec 30, 2021 | 477.80B | 21.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 67.03T |
| Celltrion | 39.38T |
| ALTEOGEN | 19.98T |
| Samsung Epis Holdings | 11.66T |
| BIT Computer | 63.68B |
| Yuyu Pharma | 60.63B |
| Sugentech | 59.86B |
| LabGenomics | 56.13B |